ARID1A

May 18, 2018

Protein Levels Could Replace Genetic Tests for Detecting ARID1A Mutations

News

A laboratory technique that measures protein levels in tissue samples — called immunohistochemistry (IHC) — is a quicker and less expensive alternative to detect ARID1A mutations in patients with ovarian and other ... Read more

May 19, 2017May 19, 2017

Clear Cell Ovarian Cancer Patients Lacking ARID1A Protein Could Benefit from ENMD-2076 Treatment, Study Reports

News

Results from a Phase 2 clinical trial indicate that an investigational drug by CASI Pharmaceuticals, known as ENMD-2076, may be beneficial for patients with rare clear cell ovarian cancer (CCOC), particularly ... Read more

January 16, 2017

Genetic Mutations Could Predict Patients Likely to Benefit from New Class of Cancer Drugs

News

Testing for mutations in ARID1A, a gene that is commonly mutated in ovarian cancers, may help predict which patients are likely to respond to a novel class of drugs currently ... Read more